Nursing Homes for Sale and Investment Opportunities

- The company is an agri-tech manufacturing startup specializing in protective farming products. - Focused on rigorous research and development processes, it fosters a culture of continuous improvement. - It has established a network of over 300 franchises across various sub-districts in Maharashtra, Gujarat, Rajasthan, Madhya Pradesh, Chhattisgarh, and Karnataka, benefiting over 15,000 farmers. - Over 50 demo farms have been set up in these sub-districts to educate farmers about the benefits of its products and modern farming techniques through weekly workshops. - These demo farms also serve as platforms for upselling and cross-selling various agricultural allied products and services. - Partnerships with several C&F agents ensure efficient last-mile delivery to farmers and franchise entrepreneurs. - A buy-back policy for Mulch Films is in place, repurchasing them from farmers for recycling after the previous crop cycle. - The company guarantees full replacement of its products in case of manufacturing defects, ensuring satisfaction for farmers. - An application developed by the company empowers farmers by providing them with insights into farming practices and the impact of protective farming techniques on their livelihoods. - The company acknowledges that enhancing productivity per unit of land is crucial for agricultural advancement, recognizing protective farming techniques as a key strategy.

- A baked clay product manufacturing company located in Zagreb. - The company has many years of experience and highly professional personnel, which enables it to offer its clients a product of the highest quality. - Accordingly, the company has a base of regular and satisfied customers throughout Croatia and also exports to Slovenia, Austria, Hungary, the Czech Republic, and some other European countries. - The business has all the required licenses.

- Platform used to digitize, simplify and automate the work of real estate. - A comprehensive suite that accompanies real estate agents and agencies on their digital transformation journey, providing all the tools to manage daily operations. Business Model - sold as a yearly subscription: - Standard (real estate agents and agency) €615/year. - Custom (large real estate group): > €3k/year. - Add-on services: €119/year. - Traction: Over 6,500 subscribers and 360,000 signatures generated, reflecting strong market adoption. - Financial Performance: Current revenue of €240,000, with projected revenue expected to reach €2.6 million in 3 years. - Profitability: Achieved a healthy EBITDA margin of 30%, highlighting sustainable financial operations. - The market for software for the real estate sector. Fits within Proptech, a sector which was worth €28 billion in 2022 and will grow by 16% annually until 2032 with three main trends. Reasons to Invest: - Strategic Growth Potential: Capitalize on a rapidly expanding market with robust revenue projections. - Experienced Leadership: Backed by a seasoned team proficient in IT development, marketing strategies, and talent acquisition. - There are 2 permanent employees who are sufficient to run the business operations. - There is a significant growth in revenue this year because the business was started mid of last year.

- Founded by industry veterans with 40 years of collective experience. - Offers a wide range of crushed stone sizes tailored to various construction needs such as base course, sub-base, and aggregates for concrete. - Catering to the booming stone crusher market driven by the increasing demand for infrastructure development. - Targeting government-backed major infrastructure projects, land developers, and residential/commercial builders. - Strengths include access to raw materials, established supply chain networks, extensive market knowledge, and a strong presence in the Indian market. - Positioned to become a leading producer of construction aggregates. - With operational capacity at 100MT/hour, running the machine for 10 hours daily yields a conservative profit estimate of 18,00,000 INR per month based on a daily output of 1000 tons. - Company set to start operations post funding.

- The company specializes in crafting B2C high fashion boots made exclusively from natural rubber, offering a completely unique product. - These boots feature a Swedish design with a captivating history, catering to vegan preferences and distinguishing themselves from conventional rubber boots by offering various shaft heights, very soft rubber, high fashion design and the boot is retro and modern at the same time. - Despite lacking marketing efforts, the company has managed to attract customers from 50 different countries, indicating strong global appeal and demand for its distinctive product. - With an impressive margin of approximately 76%, the company enjoys significant profitability, reflecting the perceived value and uniqueness of its boots in the market. - Manufacturing operations are handled by our manufacturer in China, who produces the goods according to the company's specifications. The company owns the lasts and moulds. Only this company can produce these branded boots. - The company holds proprietary rights to its moulds, safeguarding its designs and ensuring exclusivity in the market. - Trademark protection has been secured in key markets such as the EU, USA, Canada, and China for the next decade, shielding the brand from infringement and imitation. - Licenses are in place, including incorporation, further solidifying the company's legal standing and enabling smooth business operations.

- Company overview: Academy management platform and community term application aimed at revolutionizing sports analytics, particularly for EPPP Cat 1-4 football academy managers in the UK. It facilitates digital transformation, performance enhancement, and recruitment streamlining, akin to SAP/Zoho for sports with a community aspect similar to LinkedIn for athletes and parents. Recent progress: - Received 129 inquiries for the latest version launch. - Conducted 15 successful pilots, leading to valuable product validation and enhancements. - Converted 3 pilots into paid customers, including notable names like Blackburn Rovers (Cat 1 in UK) and Minerva (largest in India). - Prominent clients like Manchester City and Forest Green Rovers. - Team expertise: The team boasts 130+ years of combined experience, with backgrounds including roles such as analyst at FSG for Deloitte, player/coach at Manchester City, Blackburn Rovers, Everton, technical director at East Bengal, VP at Reliance, director of market strategy at Vedanta, vice president at La Liga, and service in the US Army, Navy, and Marines. Current focus and funding: - Currently raising $300k for the next 18 months. - Focus on expanding the customer base to 20-30 additional academies, aiming to reach 108 academies ($2.1M) but limited by bandwidth. - Initiating discussions with renowned federations like the English Premier League ($8M ARR), Virginia Youth Soccer Association ($4M ARR), Miami Soccer Association ($6M ARR). - Enhancing the product based on customer feedback to increase the academy ACV to at least $100,000.

- Drug reformulation pharmaceutical company based in Los Angeles. - Focused on developing drugs through Phase I to IV to achieve FDA approval. - Primarily directed towards improving health outcomes in the neurosciences and beyond. - Dedicated to finding innovative and effective treatment solutions to the most challenging ailments related to the Central Nervous System. - This is done by transforming positive clinical results from decades of hands-on patient care experience into rigorous scientific research. - The company has 10 patented products in its portfolio, some of which have the potential to generate annual revenues ranging from $200 million to $1 billion per product. - 4 of these products need to be moved to Phase IIb. - The products cater to critical healthcare needs in America and are planned to be established through publication on popular channels to showcase the efficacy. - Also has a network of 70,000 pharmacies, providing a robust distribution platform for its products. - While the company owns the formulation of its products, the production is outsourced through external laboratories. - Led by 8 partners with over 100 years of combined professional experience in patient care, clinical research, and entrepreneurship. They bring vast experience in CNS-related drug development, ensuring a strong foundation for the company's operations.